The prevalence of depression in isolated/idiopathic rapid eye movement sleep behavior disorder: A systematic review and meta-analysis

Sleep Med Rev. 2022 Oct:65:101684. doi: 10.1016/j.smrv.2022.101684. Epub 2022 Aug 9.

Abstract

This systematic review and meta-analysis aimed to investigate depression prevalence and depression-related symptoms among patients with isolated/idiopathic rapid eye movement sleep behavior disorder (iRBD). We systematically searched online databases (PubMed and Scopus), performed meta-analyses of psychiatric symptoms prevalence using a random-effects model, and calculated 95% prediction intervals (PIs) and I2 values to evaluate the degree of heterogeneity. We conducted a meta-regression analysis to assess the relationship between psychiatric symptom severity, age at diagnosis, and disease duration from onset of iRBD. We analyzed 31 studies which included 3,576 patients (2,871 men, 80.3%; mean age, 66.6 ± 8.6 years). The pooled depression prevalence was 28.8% (95% CI 23.1-35.2, 95% PI 8.1-65.1, and I2 = 83.9%). We found a significantly negative correlation between depression-scale scores and disease duration in iRBD (p = 0.012, β = -0.36, R2 analog = 0.33). Pooled prevalence of apathy and anxiety was 38.4% (95% CI 27.7-50.4, 95% PI 0.02-99.9, and I2 = 57.8%) and 21.3% (95% CI 15.5-28.5, 95% PI 4.2-62.6, and I2 = 47.1%), respectively. Few articles on alexithymia were available for meta-analysis. This study confirmed high prevalence of depression, apathy, and anxiety in patients with iRBD.

Keywords: Alexithymia; Anxiety; Apathy; Depression; Meta-analysis; REM sleep Behavior disorder; Systematic review.

Publication types

  • Meta-Analysis
  • Review
  • Systematic Review
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Anxiety
  • Anxiety Disorders
  • Depression / epidemiology
  • Humans
  • Male
  • Middle Aged
  • Prevalence
  • REM Sleep Behavior Disorder* / diagnosis
  • REM Sleep Behavior Disorder* / epidemiology